"Psychiatry’s future requires embracing opportunities presented by psychedelic therapies while upholding core values. These are urgent times, and the role of psychiatrists’ guidance in honoring and informing patient autonomy is critical as psychedelics reemerge in the popular and medical consciousness."
Read the full piece at Psychiatric Times
Kristel Carrington, MD, a Brooklyn native of Guyanese descent, is a board-certified psychiatrist, psychotherapist, and psychopharmacologist committed to a patient-first approach in mental health. Her education includes a Neuroscience degree from Columbia and an MD from Yale, complemented by a residency at NYU Langone Medical Center. Dr. Carrington specializes in a range of mental health treatments, is certified in psychedelic-assisted therapies, and utilizes ketamine for treatment-resistant conditions. Her work extends into biotechnology, where she contributes her expertise to a neuroscience-focused startup, enhancing early disease detection and clinical trials with AI. Dr. Carrington is also an active medical educator, mentoring the next generation of mental health professionals, demonstrating her commitment to compassionate care and the growth of psychiatric knowledge.
.svg)